Varshitha A

M.Pharm (Pharmaceutics) postgraduate with a strong interest in Pharmacovigilance, Drug Safety, and Adverse Drug Reaction (ADR) monitoring. Skilled in literature review, ADR identification, safety data analysis, pharmacovigilance databases, and scientific documentation. Academic research experience includes evaluation of the safety profile of candesartan cilexetil using WHO VigiAccess, FDA FAERS, published case reports, and pharmacovigilance literature, along with formulation and evaluation of pharmaceutical dosage forms.

Certified in Pharmacovigilance, Clinical Research, and Clinical Data Management, with a strong interest in contributing to drug safety surveillance and patient safety.

Healthcare Intern - Arogya Aadhar

(2026-03 - 2026-06)

• Exposure to EHR, healthcare data management and clinical documentation.
• Gained practical understanding of healthcare workflows.

Industrial Training - Bioplus Life Sciences Pvt. Ltd.

(2024-11 - 2024-12)

• Completed 150 hours of industrial training.
• Gained exposure to pharmaceutical industry practices and operations.

M Pharm Research – Candesartan Cilexetil Nanosuspension

• Formulation and optimization of nanosuspension with pharmacovigilance-based safety insights.
• Involved in ADR monitoring, safety-data review and literature analysis.
• Experience in formulation evaluation, data interpretation and scientific documentation.

Master of Pharmacy (M.Pharm) - Pharmaceutics - The Oxford College of Pharmacy, Bengaluru (2024-12 - 2026-11)

Bachelor of Pharmacy - The Oxford College of Pharmacy, Bengaluru (2020-12 - 2024-11)